107 related articles for article (PubMed ID: 22561131)
1. Awakening properties of newly discovered highly selective H₃ receptor antagonists in rats.
Griebel G; Decobert M; Jacquet A; Beeské S
Behav Brain Res; 2012 Jul; 232(2):416-20. PubMed ID: 22561131
[TBL] [Abstract][Full Text] [Related]
2. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.
Gao Z; Hurst WJ; Czechtizky W; Francon D; Griebel G; Nagorny R; Pichat P; Schwink L; Stengelin S; Hendrix JA; George PG
Bioorg Med Chem Lett; 2013 Nov; 23(22):6141-5. PubMed ID: 24076172
[TBL] [Abstract][Full Text] [Related]
4. Effects of modafinil and amphetamine on sleep-wake cycle after sleep deprivation in cats.
Hou YP; Lin JS
Zhongguo Yao Li Xue Bao; 1999 Sep; 20(9):813-8. PubMed ID: 11245089
[TBL] [Abstract][Full Text] [Related]
5. Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists.
Le S; Gruner JA; Mathiasen JR; Marino MJ; Schaffhauser H
J Pharmacol Exp Ther; 2008 Jun; 325(3):902-9. PubMed ID: 18305012
[TBL] [Abstract][Full Text] [Related]
6. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat.
Edgar DM; Seidel WF
J Pharmacol Exp Ther; 1997 Nov; 283(2):757-69. PubMed ID: 9353396
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice.
Guo RX; Anaclet C; Roberts JC; Parmentier R; Zhang M; Guidon G; Buda C; Sastre JP; Feng JQ; Franco P; Brown SH; Upton N; Medhurst AD; Lin JS
Br J Pharmacol; 2009 May; 157(1):104-17. PubMed ID: 19413575
[TBL] [Abstract][Full Text] [Related]
8. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.
Huang ZL; Mochizuki T; Qu WM; Hong ZY; Watanabe T; Urade Y; Hayaishi O
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4687-92. PubMed ID: 16537376
[TBL] [Abstract][Full Text] [Related]
9. First and second generation H₁ histamine receptor antagonists produce different sleep-inducing profiles in rats.
Unno K; Ozaki T; Mohammad S; Tsuno S; Ikeda-Sagara M; Honda K; Ikeda M
Eur J Pharmacol; 2012 May; 683(1-3):179-85. PubMed ID: 22449385
[TBL] [Abstract][Full Text] [Related]
10. Modulation of hippocampal theta oscillation by histamine H3 receptors.
Hajós M; Siok CJ; Hoffmann WE; Li S; Kocsis B
J Pharmacol Exp Ther; 2008 Jan; 324(1):391-8. PubMed ID: 17940197
[TBL] [Abstract][Full Text] [Related]
11. Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat.
Lin JS; Gervasoni D; Hou Y; Vanni-Mercier G; Rambert F; Frydman A; Jouvet M
J Sleep Res; 2000 Mar; 9(1):89-96. PubMed ID: 10733694
[TBL] [Abstract][Full Text] [Related]
12. Effects of modafinil on sleep-wake cycles in larval zebrafish.
Sigurgeirsson B; Thorsteinsson H; Arnardóttir H; Jóhannesdóttir IT; Karlsson KA
Zebrafish; 2011 Sep; 8(3):133-40. PubMed ID: 21882999
[TBL] [Abstract][Full Text] [Related]
13. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
[TBL] [Abstract][Full Text] [Related]
14. Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats.
Ishizuka T; Murakami M; Yamatodani A
Eur J Pharmacol; 2008 Jan; 578(2-3):209-15. PubMed ID: 17920581
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs.
Shelton J; Nishino S; Vaught J; Dement WC; Mignot E
Sleep; 1995 Dec; 18(10):817-26. PubMed ID: 8746387
[TBL] [Abstract][Full Text] [Related]
16. Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121.
Pan JB; Yao BB; Miller TR; Kroeger PE; Bennani YL; Komater VA; Esbenshade TA; Hancock AA; Decker MW; Fox GB
Life Sci; 2006 Aug; 79(14):1366-79. PubMed ID: 16730751
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of modafinil and d-amphetamine in male Sprague-Dawley rats trained to discriminate d-amphetamine.
Quisenberry AJ; Prisinzano T; Baker LE
Pharmacol Biochem Behav; 2013 Sep; 110():208-15. PubMed ID: 23880213
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of a new central adrenergic agonist--modafinil--and D-amphetamine on sleep and early morning behaviour in young healthy volunteers.
Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; Barbanoj MJ
Int J Clin Pharmacol Res; 1989; 9(3):183-95. PubMed ID: 2568348
[TBL] [Abstract][Full Text] [Related]
19. Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat.
Touret M; Sallanon-Moulin M; Jouvet M
Neurosci Lett; 1995 Apr; 189(1):43-6. PubMed ID: 7603622
[TBL] [Abstract][Full Text] [Related]
20. Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.
Dvorak CA; Apodaca R; Xiao W; Jablonowski JA; Bonaventure P; Dugovic C; Shelton J; Lord B; Miller K; Dvorak LK; Lovenberg TW; Carruthers NI
Eur J Med Chem; 2009 Oct; 44(10):4098-106. PubMed ID: 19524331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
